ClinicalTrials.gg
CompletedNCT06531954Updated Aug 1, 2024

Breathing Exercises and Auricular Vagus Nerve Stimulation

A Phase 2 interventional study of Vagus nerve stimulation and Breathing exercise in Breathing Exercises, Auricular Vagus Nerve Stimulation and Autonomic Nervous System, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-01.

Sponsored by Istanbul Medipol University Hospital · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Jan 2021, registered Jul 2024).
Phase
Phase 2
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Introduction: Vagal modulation is achieved directly by transcutaneous auricular vagus nerve stimulation, whereas breathing exercises stimulate arterial baroreceptors. In this study, we aimed to compare these two methods, which have similar effects.

Methods: 88 healthy participants aged 18-35 were randomly divided into breathing exercises (Group BE) and vagus stimulation (Group VNS). Thoracic expansion exercise was performed in the BE group. In the VNS group, biphasic electrical stimulation was applied to both ears with a pulse width of 300 microseconds, frequency of 10 Hz, and 20 minutes. Pulmonary function tests were measured on the first and last day. Heart rate, systolic and diastolic blood pressure, RMSSD, PNN50, LF/HF, LF Power, and HF Power values were measured before and after each of the ten sessions for both groups.

02

Conditions studied

  • Breathing Exercises
  • Auricular Vagus Nerve Stimulation
  • Autonomic Nervous System

Keywords

  • Breathing Exercises
  • Autonomic Nervous System
  • Pulse Rate Variability
  • Respiratory Functions
  • Auricular Vagus Nerve Stimulation
03

In context

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 365 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy individuals between the ages of 18 and 35,
  • without orthopedic disability,
  • without any chronic disease and regular medication use,
  • who had not smoked for the last year,
  • who had no problems in reading, writing, or comprehension were included in our study.

Exclusion criteria

Exclusion Criteria:

  • active or chronic respiratory diseases and communication problems because they may adversely affect pulmonary function testing
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
88 participants (actual)

Study arms

  • Active comparator
    Breathing exercise group (BE)

    The content of breathing exercises was planned as thoracic expansion exercises. These exercises were applied to the lower, middle, and upper lobes in 3 sets of 3x10 (90 times breathing in one area) and lasted for an average of 20 minutes. These exercises were first taught by the physiotherapist and performed under her supervision. Participants were asked to inhale as deeply as possible into the relevant area, hold their breath for 3 seconds, and then slowly exhale the entire breath.

    Behavioral: Breathing exercise

  • Experimental
    Vagus nerve stimulation group (VNS)

    Vagus stimulation was applied bilaterally through the ear. taVNS was performed with the Vagustim device. The stimulation pulse width was 300 microseconds, the frequency was 10 Hz, and it was biphasic with a 20-minute duration. Electrodes were placed on the concha and tragus parts of the ear, and the current was increased through these electrodes until the participant felt pain. When the participant felt pain, the intensity was reduced to a comfortable sensation.

    Device: Vagus nerve stimulation

Interventions

  • DeviceVagus nerve stimulation

    Vagus nerve stimulation group: Vagus stimulation was applied bilaterally through the ear. taVNS was performed with the Vagustim device. The stimulation pulse width was 300 microseconds, the frequency was 10 Hz, and it was biphasic with a 20-minute duration. Electrodes were placed on the concha and tragus parts of the ear, and the current was increased through these electrodes until the participant felt pain.

  • BehavioralBreathing exercise

    Breathing exercise group: The content of breathing exercises was planned as thoracic expansion exercises. These exercises were applied to the lower, middle, and upper lobes in 3 sets of 3x10 (90 times breathing in one area) and lasted for an average of 20 minutes. Participants were asked to inhale as deeply as possible into the relevant area, hold their breath for 3 seconds, and then slowly exhale the entire breath.

06

What researchers measure

Primary outcomes

  1. Autonomic nervous system activity

    Autonomic measurements of each individual participating in the study before and after the intervention were performed with heart rate variability parameters. For this purpose, the Elite HRV device was used. The device has a finger sensor and an application compatible with the phone. Elite HRV application is a software that can synchronize with a personal monitor by collecting peak-to-peak intervals for instant analysis of pulse rate variability (PRV). In addition to all these assessments, blood pressure measurements of the participants were also evaluated using an Omron M2 electronic sphygmomanometer on the right arm.

    Time frame: pre-intervention, immediately after-intervention

  2. Pulmonary Function. Forced expiratory volume in the first second (FEV1)

    Participants in both groups underwent pulmonary function test evaluation on the first and last day. Since the study was conducted in healthy individuals, it was deemed appropriate to look at the pulmonary function test before and after exertion to see possible changes. Medwelt SP10 spirometer was used for pulmonary function tests in our study. Each individual was measured in a sitting position using a separate mouthpiece.

    Time frame: pre-intervention, immediately after-intervention

  3. Pulmonary Function. Forced vital capacity (FVC)

    Participants in both groups underwent pulmonary function test evaluation on the first and last day. Since the study was conducted in healthy individuals, it was deemed appropriate to look at the pulmonary function test before and after exertion to see possible changes. Medwelt SP10 spirometer was used for pulmonary function tests in our study. Each individual was measured in a sitting position using a separate mouthpiece.

    Time frame: pre-intervention, immediately after-intervention

07

Study locations

1 site
  • Mudanya University
    Bursa, 16160, Turkey (Türkiye)
08

References and documents

Publications

  • Hatik SH, Arslan M, Demirbilek O, Ozden AV. The effect of transcutaneous auricular vagus nerve stimulation on cycling ergometry and recovery in healthy young individuals. Brain Behav. 2023 Dec;13(12):e3332. doi: 10.1002/brb3.3332. Epub 2023 Nov 16. PubMed 37974551 ↗

Individual participant data

Plan to share: Yes — Our study was conducted as a randomized prospective study. In both groups, the interventions were performed for ten sessions for two weeks, five days a week. In both groups, heart rate variability, heart rate, and blood tension were measured before and after each session, and the pulmonary function test was evaluated the day before and the day after the ten sessions of applications. Since the study was conducted in healthy participants, pulmonary function tests were examined Before and after aerobic training to see possible changes. The training on the treadmill consisted of 5-minute warm-ups, 20 minutes of loading, and five 5-minute cool-down periods. Participants performed warm-up and cool-down periods at a treadmill speed of 4km/h. After determining the maximum heart rate according to the 220-age formula, the loading intensity was performed at 60% of this value [4]. Intergroup comparisons were made as a result of the evaluations in both groups.

Supporting information: Study protocol

Time frame: a year

Access criteria: nervus vagus stimulation

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06531954
Responsible party
gulay karacaoglu (Doctor, Istanbul Medipol University Hospital) — Principal investigator
First posted
Aug 1, 2024
Start date
Jan 2, 2021
Primary completion
Jan 3, 2022
Completion
Mar 1, 2023
Last update
Aug 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion